ADVENT LTO Study
Brief description of study
This is an observational, non-significant risk study. Subjects who completed participation in the FARAPULSE ADVENT Trial will be approached for participation. Subjects who agree to participate will complete a 7-day Holter monitor, quality of life questionnaire, and the subjects arrhythmia-related medical history will be assessed from the time of completion of the ADVENT Trial to at least three (3) years post-Index Procedure.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
